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Human exposure to hexavalent chromium
compounds has been firmly linked with the
induction of cancer (1,2). Chromate, or dichro-
mate, in fact, easily enters cells through the sul-
fate channel (3) and is quickly reduced by
glutathione (GSH) (4), ascorbic acid (4), or
cysteine (Cys) (4,5). In exposed animals, the
ultimate step of the metabolic pathway yields
Cr(III) inserted within the cell nucleus, where
it cross-links DNA to proteins (mainly actin) or
GSH (6,7). The intermediate steps have not
been thoroughly characterized so far, although
Cr(V) and Cr(IV) compounds have been
demonstrated to produce reactive oxygen
species, thiyl, and carbon-based radicals (8–12).
Despite such toxic features, Cr(III) is
essential in mammals that require it for nor-
mal carbohydrate and lipid metabolism
(13–15). Since the so-called glucose tolerance
factor failed to be chemically characterized
(16), chromium tris-picolinate [Cr(pic)3] has
been proposed as the biologically active form
of Cr(III) and extensively commercialized
(17–19). In the early 1980s a new chromium-
binding oligopeptide, named “low-molecular-
weight chromium” (LMWCr) (15,20–31),
also known as chromodulin (32), was isolated
in tissues, mainly in the liver, of several
mammals (24). Moreover, the use of Cr(pic)3
as a dietary supplement has been challenged
by its proven features of a) catalytically pro-
ducing hydroxyl radicals and b) being poten-
tially mutagenic as are all other Cr(III)
compounds (33).
LMWCr has been investigated extensively
for its chemical and biological features
(28,29,34):
• The protein is isolated with the best yield
from bovine liver, with few separation pro-
cedures (10–30 mg of protein from 1 kg of
diced liver).
• Ultraviolet–visible spectrum (UV-vis), elec-
tron paramagnetic resonance (EPR), and
nuclear magnetic resonance (NMR) features
suggest the presence of a peptide-bound
cluster of four oxo-bridged octahedral
Cr(III) ions.
• The protein a) increases the ability of rat
adipocytes to metabolize glucose (in the
presence of insulin); b) stimulates glucose
metabolism in a way proportional to its
chromium contents; and c) does not change
the concentration of insulin required for
half-maximal stimulation.
• The average molecular weight is approxi-
mately 1.5 kDa.
• The protein is composed of only four
amino acids [glutamate (Glu), aspartate
(Asp), glycine (Gly), Cys] in the average
ratio Glu:Asp:Gly:Cys = 2.15:4.47:2.47:2.35.
• The apo-protein may be generated (29), but
no delineation has been provided of its
chemical and spectroscopic features.
All these, and other properties (35), are
therefore flawed by the impossibility of
determining the primary sequence of the
protein (29).
We also considered that the reported
composition of LMWCr roughly corresponds
to two GSH, two Asp, and two Glu mole-
cules, and that the intermediate steps of
metabolic reduction of Cr(VI) are worth fur-
ther investigation.
For these two reasons, we present our
spectroscopic UV-vis, electrospray mass spec-
trometry (ES-MS), and EPR and NMR stud-
ies of a) the products of Cr(VI) reduction by
GSH alone or in the presence of equimolar
quantities of Asp and/or Glu, and b) the
chromium-containing material extracted
from bovine liver.
A ﬁrst report of some preliminary results
has been published elsewhere (36).
Materials and Methods
All chemicals were obtained from Sigma
Chemical Co. (Milano, Italy) and used with-
out further puriﬁcation. The extraction of the
chromium-containing material from the
bovine liver was performed by exactly follow-
ing the already published protocol (29).
Solutions were obtained in deuterium oxide
buffered at pH 7.4 and deoxygenated by
freeze–thaw cycles.
NMR spectra were obtained on 4.7, 11.7,
14.1, and 18.8 T Bruker NMR spectrometers
(Bruker, Rheinstetten/Karlsruhe, Germany)
at temperatures controlled at ± 0.2 K.
Chemical shifts were referenced to external
tetramethylsilane. COSY (correlation spec-
troscopy), TOCSY (total correlation spec-
troscopy), NOESY (nuclear Overhauser effect
spectroscopy), and ROESY (rotating frame
Overhauser effect spectroscopy) two-dimen-
sional experiments were performed by using
standard sequences. While TOCSY and
COSY relate through bonds-coupled nuclei,
NOESY and ROESY relate nuclei close in
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space coupled via dipolar interaction.
Spin-lattice relaxation rates were measured
with inversion recovery pulse sequences and
calculated by exponential regression analysis of
the decay curves of longitudinal magnetization
components.
UV-vis absorption spectra were taken on
an HP 8453 spectrometer (Hewlett Packard,
Palo Alto, CA, USA) equipped with the HP
UV-vis Chemstation software (Hewlett
Packard 95-98, Rev.A.06.04[48]). Quartz
cells with a 1.0-cm path length were used.
X-band EPR spectra were acquired on a
Bruker 200D SRC spectrometer (Bruker) at
temperature = 298 ± 0.5 K. Microwave fre-
quencies were measured with an XL
Microwave 3120 counter (Jagmar, Krakow,
Poland). The spectrometer was interfaced with
a PS/2 Technical Instruments Hardware com-
puter, and the data were acquired using the
EPR data system CS-EPR, produced by Stelar
Inc. (Mede, Italy). The spectra were prelimi-
narily corrected for baseline drift. EPR spectra
at 282 GHz were acquired under the following
conditions: temperature = 10 K, microwave
frequency = 282 GHz, ﬁeld modulation fre-
quency = 9.50 kHz, modulation amplitude =
40 mA, time constant = 3 s, sweep rate = 0.3
T/min. The simulated spectrum was calculated
by using a program written by Weihe
described in Jacobsen et al. (37). For two
unpaired electrons considered as point dipoles,
the following formula can be applied (38):
[1]
where D is one of the parameters for zero
ﬁeld splitting (the other, E, is zero). This for-
mula yields D = –0.0811 cm–1 when the two
dipoles are 0.414 nm apart. The other para-
meter for the simulation was the single-crystal
EPR line width taken at 100 mT.
ES–MS spectra were recorded with a
Perkin Elmer Sciex triple quadrupole liquid
chromatography/mass spectrometry/mass
spectrometry (LC/MS/MS) with a water/
formic acid (equilibrated at pH 7.4) mobile
phase. The ion at m/z 717 was selected and
passed through a collision cell into a second
mass analyzer.
Molecular structures were generated by
the HYPERCHEM software package (39)
implemented on a Pentium 120-MHz PC by
using the Huckel semi-empirical method for
charge calculations and the MM+ force ﬁeld
for molecular mechanics and dynamics calcu-
lations (39).
Results and Discussion
The reduction of chromate by GSH at pH
7.4 was first investigated by UV-vis spec-
troscopy (Figure 1). As previously noted (4),
the progressive disappearance of the chromate
absorption at approximately 345 nm was
accompanied by the appearance of a strong
broad absorption centered at 435 nm and
attributed to a Cr(VI)–thioester species (40).
That this last is a transient species is clearly
demonstrated by the kinetic plot shown in
Figure 2: within the first 10–15 min, it has
almost disappeared and only a strong absorp-
tion in the UV region at approximately 206
nm is left, suggesting exclusive formation of
Cr(V) or Cr(IV) species (4).
NMR spectra, recorded at 14.1 T on a
solution containing GSH and GSSG (the
oxidized form of GSH) at a ratio of 5:1 (pH
7.4) upon progressive addition of sodium
chromate (Figure 3), allowed us to make rele-
vant inferences on the formed species. The
relevant resonances are labeled in Figure 3
and are related to the chemical formulas in
Figure 4. The spectra clearly demonstrate for-
mation of GSSG at the expense of GSH.
Lowering and raising, respectively, of the
intensities of well-separated lines is in fact
observed. However, the extensive broadening
and the upfield shift experienced by reso-
nances belonging to GSH indicate the forma-
tion of a paramagnetic complex in which
GSH acts as a ligand. In fact, both 1H and
13C-NMR chemical shifts were selectively
affected, and proton spin-lattice relaxation
rates were selectively enhanced (Figures 5, 6).
Assignment of binding donors of GSH
was based on analysis of NMR parameters
yielding the following evidence:
• Cys Hα , γ -Glu Hα , γ -Glu Hβ , and γ -Glu
Hγ were the most upﬁeld-shifted GSH 1H
signals upon addition of chromate.
• All proton spin-lattice relaxation rates were
consistently enhanced, with protons within
the Cys and Glu moieties being more
affected than those of Gly.
• Cys Cα , γ -Glu Cα , and γ -Glu Cβ were the
most affected GSH 13C signals upon addi-
tion of chromate.
Both the change in chemical shifts and
the enhancement of relaxation rates are larger
at closer distances from the metal center that
provides dipolar and hyperﬁne local ﬁelds at
the nearby nuclei (41,42).
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Figure 1. UV-vis spectra of sodium chromate solution at pH 7.4 (temperature
= 300 K) as a function of time (t) after the addition of GSH.
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Figure 2. Absorbance at 435 nm of sodium chromate solution at pH 7.4 (tempera-
ture = 300 K) as a function of time after the addition of GSH.Environmental Health Perspectives • VOLUME 110 | SUPPLEMENT 5 | OCTOBER 2002 735
The dipolar contribution to the chemical
shift relies on a large value of the anisotropy
of magnetic susceptibility (42), which does
not manifest in EPR spectra. Only the
contact contribution therefore needs to be
considered, given by:
[2]
where A is the contact coupling constant, h
the reduced Planck’s constant (≡ h/2π ), µB is
the electron Bohr magneton, S is the total
spin number, γ N is the magnetogyric ratio, k
is the Boltzmann constant, and T is tempera-
ture. This equation states that an electron
spin magnetic moment determines the shift
of coupled nuclear resonances. The size of the
shift experienced by any nuclear spin in a
given metal complex is therefore determined
by A, which in turn is proportional to the
unpaired electron spin density at the nucleus.
On the other hand, the relatively long
electron relaxation times expected for S = 1/2
metal ions (41,42) make the contact contri-
bution to nuclear spin-lattice relaxation negli-
gible. The longitudinal relaxation rate of a
nucleus sensing the electron magnetic
moment can therefore be approximated by
the dipole–dipole interaction, as described by
Solomon (43). Solomon’s equation considers
the dipole–dipole interaction of nuclear and
electron magnetic moments at a certain dis-
tance r from each other. The obtained relax-
ation rate is determined by the squared
dipole–dipole interaction energy that is
modulated by molecular tumbling in solu-
tion. The mathematical expression is (43)
[3]
where µo is vacuum permeability, ω H and ω e
are the proton and electron Larmor frequen-
cies, τ c is the motional correlation time, and r
is the proton–metal distance. The isotropic
hyperfine coupling of the unpaired electron
with the metal nuclear spin modifies the
Solomon equation (44); moreover, the Curie
mechanism (42) is likely to contribute the
nuclear relaxation pathway at the high mag-
netic field used. However, the dependence
upon the inverse of r to the sixth power is
maintained in any case. As a consequence, a
large relaxation rate enhancement indicates
spatial proximity of the paramagnetic center
to the corresponding proton.
NMR data therefore support the exclu-
sion of Cys sulfhydryl and Gly carboxylate
from the possible donor set to the paramag-
netic chromium ion.
The results obtained by ES–MS and EPR
(both at 9.5 and 282 GHz) provided unequiv-
ocal evidence of the predominance of a
dimeric Cr(V)2GSH2 species (36) in which
the two metal ions are bridged by the γ -Glu
carboxylate, as conﬁrmed by the structure of
several polynuclear chromium complexes (34).
Structural details of this cluster are shown in
Figure 7; it is apparent that the γ -Glu amino
and the γ -Glu amide groups complete the
coordination donor set to chromium (36).
Repetition of the same experiments in the
presence of Asp at a concentration equimolar
to GSH yielded the following evidence:
• 1H-NMR signals of GSH and Asp are both
affected by reduced chromate, and the
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Figure 3. 1H-NMR spectra of a solution of GSH (16.7 mM) and GSSG (3.3 mM) in heavy water (D2O; pH 7.4,
temperature = 300 K) (bottom) upon addition of sodium chromate 1, 5, 10, and 20 mM (from bottom to top).
The spectrum on top was recorded 30 min after the last step of the titration.
Figure 4. Chemical formulas of GSH, Asp, and Glu.
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Figure 5. Chemical shift deviations (∆δ , ppm) and
paramagnetic contributions to spin-lattice relax-
ation rates (R1p, s–1) of GSH protons (16.7 mM) in
the presence of sodium chromate (5 mM, tempera-
ture = 300 K).
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Figure 6. Chemical shift deviations (∆δ , ppm) of
GSH carbons (16.7 mM) in the presence of sodium
chromate (5 mM, temperature = 300 K).relaxation enhancements of GSH are
further enhanced (Figure 8).
• EPR spectra indicate occurrence of a similar
species with the same electronic g factor
value and slightly broader signals (Figure 9).
• NOESY spectra give evidence of cross-peaks
between Asp protons and GSH protons,
indicating that both participate in metal
binding (Figure 10A).
• 1H-NMR dispersion curves of water pro-
tons (Figure 11) demonstrate that water
bound to paramagnetic chromium in the
Cr(V)2GSH2 species is not displaced by
Asp, with consequent decrease in the relax-
ivity. On the contrary, relaxation rates of
water protons are further enhanced, thus
indicating that, most probably the correla-
tion time has slowed in the presence of Asp,
which enhances the molecular complexity.
We therefore conclude that both Asp
and GSH bind chromium in a dimeric
Cr(V)2GSH2Asp2 complex, the structure of
which was indeed solved by molecular
mechanics and dynamics restrained by con-
straints obtained from NMR data (Figure 12).
It turns out that the two Cr(V) ions are now
bridged by Asp, which lets them reach a
Cr–Cr distance of 0.343 nm to be compared
with the Cr distance found for the
Cr(V)2GSH2 complex (0.414 nm). This short-
ened distance is consistent with the broader
EPR lines and, taken together with the
increase in molecular complexity, also with the
Asp-induced enhancement of proton relax-
ation rates of either GSH or bound water.
When Glu was also included in the solu-
tion mixture exposed to chromate additions
in equimolar concentration with both GSH
and Asp, the following results were obtained:
• 1H-NMR signals of GSH, Asp and Glu
were all affected by reduced chromate, but
the relaxation enhancements of GSH and
Asp are somehow reduced (Figure 8).
• No GSH–Glu or Asp–Glu cross-peaks are
detectable in NOESY spectra, in which the
GSH–Asp connectivities are washed out
also (Figure 10B).
• 1H-NMR dispersion curves of water pro-
tons (Figure 11) demonstrate that Glu
almost completely destroys the enhance-
ment induced by Asp, such that occurrence
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Figure 9. X-band EPR spectra of a solution of
sodium chromate and GSH in the absence (black)
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Figure 10. Selected regions of NOESY spectra of a solution of sodium chromate, GSH, and Asp in the
absence (A) and in the presence (B) of Glu.
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Figure 11. 1H-NMR dispersion curves (R1 vs ν 0) of
water protons of a 5 mM solution of sodium chro-
mate in the presence of GSH, GSH + Asp, and GSH
+ Asp + Glu (16.7 mM each; temperature = 300 K).
Figure 7. (A) Stick model of dimeric Cr(V)2GSH2
complex as determined by NMR and EPR con-
straints. Coloring scheme: chromium, green; oxy-
gen, red; carbon, cyan; hydrogen, light gray;
nitrogen, blue; sulfur, yellow. (B) Details of the
Cr–Cr cluster.
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Crof GSH, Asp, and Glu in the same metal
complex can be reasonably excluded.
We therefore conclude that Glu, Asp, and
GSH compete with each other for chromium,
with the possible simultaneous formation of
many mono- and dinuclear species. Although
GSH alone or together with Asp succeeds in
clustering chromium, the three ligands
together do not cluster chromium and give
rise to complex equilibria in solution.
The material extracted from bovine liver
was ﬁnally investigated. Although the already
published protocol (29) was exactly followed
and repeated 3 times, what we found was
quite different from the published features of
LMWCr (28,29,34):
• UV-vis spectra (Figure 13) are very similar
to those obtained in the GSH/GSSG mix-
ture upon addition of chromate at pH 7.4
and exclude whatever possibility of having
Cr(III) in the solution.
• ES–MS spectra (Figure 14) exclude the
occurrence of detectable species at m/z
> 786.4.
• The first recorded NMR spectrum (Figure
15A) is consistent with a very broad para-
magnetic signal that superimposes to a well-
resolved diamagnetic region. Moreover, a
down-shifted broad signal at +65 ppm
appears that somewhat resembles the one
observed with LMWCr (29). However, the
spectrum obtained at higher frequency
(Figure 15B) with an NMR “old-fashioned”
probe (without gradients) reveals that this
feature is an artifact; on the contrary, some
features do appear in the upfield-shifted
region (–20 ↔ –40 ppm). These findings
conﬁrm the absence of Cr(III) and indicate
the occurrence of paramagnetic Cr(IV) or
Cr(V) compounds.
• The EPR spectrum (Figure 16) is again very
similar to that obtained in the GSH/GSSG
mixture upon addition of chromate.
All the obtained results indicate that what
we have extracted from bovine liver is a com-
plicate mixture of Cr(V) complexes, among
which some Cr(V)–GSH species are present
alone or with other ligands in the metal
coordination sphere.
We conclude that what we have
investigated so far suggests that GSH not
only is a primary target for oxidation by chro-
mate but also acts as an efﬁcient ligand stabi-
lizing Cr(V) in a dimeric bridged cluster.
When Asp is also present in the medium, it
may act as an additional ligand to Cr(V) with
formation of a new type of dinuclear cluster.
If Asp and Glu are both present in the
medium, together with GSH, the three lig-
ands compete for the metal and a complicate
mixture of species in equilibrium is observed.
It is worth emphasizing that what we obtain
by reducing chromate in vitro with GSH,
GSH + Asp, or GSH + Asp + Glu represents
a good model for the mixture of species that
is detected when dichromate, added to
homogenized liver in the first step of the
extraction of LMWCr (29), is reduced and
complexed by endogenous ligands occurring
in the cell cytoplasm.
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Figure 12. Stick model of dimeric Cr(V)2GSH2Asp2
complex as determined by NMR structural con-
straints. Coloring scheme: chromium, white; oxy-
gen, red; carbon, cyan; hydrogen, light gray;
nitrogen, blue; and sulfur, yellow.
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Figure 13. UV-vis spectra of a solution of sodium
chromate (red), sodium chromate in the presence
of GSH (cyan), the material extracted from liver
(black), and Cr(III) (blue) (temperature = 300 K).
Figure 14. Regions of ES–MS spectrum of the material extracted from liver.
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Figure 15. 1H-NMR spectra of the material
extracted from liver recorded at (A) 600 MHz and
(B) 800 MHz (temperature = 300 K).
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Figure 16. X-band EPR spectra of chromium–GSH
complex (black) and the material extracted from
liver (blue) (temperature = 298 K).REFERENCES AND NOTES
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